Intellia Therapeutics Inc. (NTLA) Dropped -6.69% or -2.18 To Price $30.42 On Monday


Intellia Therapeutics Inc. (NTLA) dropped -6.69% or -2.18 to $30.42. It is about 788942 shares traded, which is 73.95% compare to the average total volume 1.07 million. The market cap of NTLA is $1.31 billion. The year to date change is 44.87%. The 52 week price range is from $14.45 to $35.99. Price of NTLA have changed 3.95% during last week. It have changed 12.61% over last month, 49.89% over last 3 months, 58.79% over last 6 months and 96.15% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 26.59. It is -12.59% below current price. The 200-day Moving Averages for NTLA is 24.26. It is -20.25% below current price. The 52-week High is 35.99. It is 18.31% from the current price. The 52-week Low is 14.45. It is -52.50% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NTLA is 6.05 on 2018-06-29. Short % to float is 17.61%. There are some statistics of NTLA. It is has market cap $1.31 billion. The share outstanding is 43.09 million. The average volume is 1.07 million. The revenue is 13.23M. The percent of top 15 Institution holding is 87.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -28.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -22.34%.


Tags:

Share this post